Scientific programme - Global Congress on Prostate and Bladder Cancer

Scientific programme

PROSCA on-demand

Watch expert presentations on prostate cancer from Saturday 10 October 2020 onwards.

Registered delegates will receive an email with the link to the presentations.
 

PROSCA live broadcast

14 October 2020
19:00-22:00 (CEST)
Moderator: Bertrand Tombal

Watch the highlights of the presentations and learn more on PCa with case discussions and debates.

BLADDR on-demand

Watch expert presentations on bladder cancer from Saturday 10 October 2020 onwards.

Registered delegates will receive an email with the link to the presentations.
 

BLADDR live broadcast

15 October 2020
19:00-22:00 (CEST)
Moderator: Eva Comperat

Watch the highlights of the presentations and learn more on BCa with live case discussions and debates.

PROSCA 2020 On-demand presentations

From Saturday 10 October 2020 onwards

Session 1
Controversies in localised prostate cancer
The role of MRI in active surveillance
Johan Stranne

Robotic surgery: new techniques for continence preservation
Ashutosh Tewari

 

Debate: Intermediate-risk prostate cancer: patients do care if QoL is fair
Panel: Alberto Bossi, Christian Gratzke, Alison Tree

Session 2
Advanced prostate cancer

Treatment advances in mHSPC
Ursula Vogl

The current landscape of nmCRPC
Charles Ryan

Immunotherapy for advanced prostate cancer: progress and new hopes
Petros Grivas

Session 3
What’s the role of novel imaging in daily clinical practice?
PSMA-PET: does it make a difference for patients at high-risk for de novo N1 disease?
Jeremie Calais
How to deliver a high-quality diagnostic service: focus on MRI
Anwar Padhani
Session 4
Genetic testing in practice

 

Genetic testing for prostate cancer: are you ready?
Derya Tilki

PARP inhibitors: which patients will benefit?
Elena Castro

PROSCA 2020 Live broadcast

Wednesday 14 October 2020

19:00 – 22:00 (CEST)

Moderator: Bertrand Tombal

 

19:00
Welcome

Bertrand Tombal

19:10
Controversies in localised prostate cancer

Panel: Siska Van Bruwaene, Piet Dirix
Presenters: Johan Stranne, Ashutosh Tewari
Case discussion panel: Alberto Bossi, Christian Gratzke, Alison Tree

Key messages

  • The role of MRI in active surveillance
  • Robotic surgery
  • Intermediate-risk prostate cancer: patients do care if QoL is fair
 

Voting & case discussion

Q&A

Summary

19:45
Short break
19:50
Advanced prostate cancer

Panel: Daan De Maeseneer
Presenters: Ursula Vogl, Charles Ryan, Petros Grivas

Key messages

  • Treatment advances in mHSPC
  • The current landscape of nmCRPC
  • Immunotherapy for advanced prostate cancer: progress and new hopes
 

Voting & case discussion

Q&A

Summary

20:25
Best posters
20:30
Break
20:40
What’s the role of novel imaging in daily clinical practice?

Panel: Piet Ost, Nicolas Mottet
Presenters: Jeremie Calais, Anwar Padhani

Key messages

  • PSMA-PET: does it make a difference for patients at high-risk for de novo N1 disease?
  • How to deliver a high-quality diagnostic service: focus on MRI
 

Voting & case discussion

Q&A

Summary

21:15
Short break
21:20
Genetic testing in practice

Panel: Piet Ost
Presenters: Derya Tilki, Elena Castro

Key messages

  • Genetic testing for prostate cancer: are you ready?
  • PARP inhibitors: which patients will benefit?
 

Voting & case discussion

Q&A

Summary

21:55
Wrap up

BLADDR 2020 On-demand presentations

From Saturday 10 October 2020 onwards

Session 1
New options in NMIBC
Intravesical alternatives to BCG
Kilian M. Gust

BCG-refractory NMIBC: what now?
Ashish Kamat

 

Prognostic markers: role in follow-up of patients with NMIBC
Hugh Mostafid

Session 2
MIBC

Neoadjuvant and adjuvant therapy: what did we learn in 2020 and what can we expect in the near future?
Maria De Santis

Variant histologies: what’s new?
Eva Comperat

Robotic intracorporeal urinary diversion: does it pay off?
Frederiek D’Hondt
Advances in RT: focus on hypofractionation
Peter Hoskin
RT + IO: a golden combination?
Shaista Hafeez
Session 3
Advanced UCa
Optimising treatment for advanced UCa: combination, maintenance or sequencing?
Arlene Siefker-Radtke

Metastatic UCa: a glimpse of the near future
Ignacio Durán

cN+ M0 BCa: curative or palliative treatment plan?
Marco Moschini

BLADDR 2020 Live broadcast

Thursday 15 October 2020

19:00 – 22:00 (CEST)

Moderator: Eva Comperat

 

19:00
Welcome

Eva Comperat, Piotr Chlosta

19:10
New options in NMIBC

Panel: Jacques Irani, Jeroen van Moorselaar
Presenters: Kilian M. Gust, Ashish Kamat, Hugh Mostafid

Key messages

  • Intravesical alternatives to BCG
  • BCG-refractory NMIBC: what now?
  • Prognostic markers: role in follow-up of patients in NMIBC
 

Voting & case discussion

Q&A

Summary

19:55
Break
20:05
MIBC

Panel: Frederiek D’Hondt, Valérie Fonteyne
Presenters: Maria De Santis, Eva Comperat, Frederiek D’Hondt, Peter Hoskin, Shaista Hafeez

Key messages

  • Neoadjuvant and adjuvant therapy: what did we learn in 2020 and what can we expect in the near future?
  • Variant histologies: what’s new?
  • Robotic intracorporeal urinary diversion: does it pay off?
  • Advances in RT: focus on hypofractionation
  • RT + IO: a golden combination?
 

Voting & case discussion

Q&A

Summary

20:50
Best posters
20:55
Break
21:05
Advanced UCa

Panel: Karel Decaestecker, Emmanuel Seront
Presenters: Arlene Siefker-Radtke, Ignacio Durán, Marco Moschini

Key messages

  • Optimising treatment for advanced UCa: combination, maintenance or sequencing?
  • Metastatic UCa: a glimpse of the near future
  • cN+ M0 BCa: curative or palliative treatment plan?
 

Voting & case discussion

Q&A

Summary

21:55
Wrap up
Legend:
Lecture
Debate/ panel discussion
Q&A

Mirrors of Medicine

Organised by
ISSECAM

Congress management by
e-HIMS